휴런

비상장계속사업자

Heuron Co.,Ltd.

신동훈

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

휴런

Business Reg. No. 7288600780 · CEO 신동훈

I.Investment Overview

Target휴런 (7288600780)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명휴런
영문명Heuron Co.,Ltd.
대표자신동훈
사업자등록번호7288600780
법인등록번호1311110500338
설립일2017.11.24

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW2.220223.720238.920243.52025
영업이익100M KRW-962022-822023-79.12024-41.42025
순이익100M KRW-543202154.72022-7.62023-5.5202421.62025
Item20252024202320222021
자산총계59.3억원55.9억원117.1억원186.6억원267.1억원
부채총계300.6억원309.5억원384.4억원460.1억원611.3억원
자본총계-241.2억원-253.6억원-267.3억원-273.5억원-344.2억원
매출액3.5억원8.9억원3.7억원2.2억원
영업이익-41.4억원-79.1억원-82억원-96억원
순이익21.6억원-5.5억원-7.6억원54.7억원-543억원

VI.Financial Ratios

FY2025 basis

-1,178.25%

영업이익률

614.3%

순이익률

36.38%

ROA

ROE

부채비율

자기자본비율

VII.R&D Activity

Fields 보건의료 > 의료기기

Keywords 뇌졸중, 뇌경색, 인공지능

YearProjectsPapersPatents
2025110
2024200
2023200

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

휴런 투심보고서 | Alpha Lenz